NCT01916265View on ClinicalTrials.gov

Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Diabetes Mellitus Type 1
Interventions
DRUG

Glucagon

Trial Locations (1)

41460

Profil Institut für Stoffwechselforschung GmbH, Neuss

All Listed Sponsors
collaborator

European Union

OTHER

lead

Profil Institut für Stoffwechselforschung GmbH

INDUSTRY

NCT01916265 - Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages | Biotech Hunter | Biotech Hunter